+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A Nonhuman Primate Transplantation Model to Evaluate Hematopoietic Stem Cell Gene Editing Strategies for β-Hemoglobinopathies



A Nonhuman Primate Transplantation Model to Evaluate Hematopoietic Stem Cell Gene Editing Strategies for β-Hemoglobinopathies



Molecular Therapy. Methods and Clinical Development 8: 75-86



Reactivation of fetal hemoglobin (HbF) is a promising approach for the treatment of β-hemoglobinopathies and the targeting of genes involved in HbF regulation is under intensive investigation. Here, we established a nonhuman primate (NHP) transplantation model to evaluate hematopoietic stem cell (HSC)-based gene editing strategies aimed at reactivating HbF. We first characterized the transient HbF induction to autologous HSC transplantation in pigtailed macaques, which was comparable in duration and amplitude to that of human patients. After validating function of the HbF repressor BCL11A in NHPs, we transplanted a pigtailed macaque with CD34+ cells electroporated with TALE nuclease mRNA targeting the BCL11A coding sequence. In vivo gene editing levels were low, but some BCL11A deletions were detected as late as 200 days post-transplantation. HbF production, as determined by F-cell staining and γ-globin expression, was slightly increased in this animal as compared to transplant controls. We also provided proof-of-concept results for the selection of edited NHP CD34+ cells in culture following integration of the P140K/MGMT cassette at the BCL11A locus. In summary, the NHP model described here will allow the testing of novel therapeutic approaches for hemoglobinopathies and should facilitate clinical translation.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 047847864

Download citation: RISBibTeXText

PMID: 29276718

DOI: 10.1016/j.omtm.2017.11.005


Related references

A Nonhuman Primate Transplantation Model to Evaluate Gene Editing Strategies Aimed at Inducing Fetal Hemoglobin Production for the Treatment of Hemoglobinopathies. Molecular Therapy 24: S299-S300, 2016

Hematopoietic stem cell expansion facilitates multilineage engraftment in a nonhuman primate cord blood transplantation model. Experimental Hematology 40(3): 187-196, 2012

In vivo small primate model for human hematopoietic stem cell gene therapy Docetaxel treatment of marmosets with retrovirally MDR1 gene transduced hematopoietic stem cell. Blood 90(10 Suppl. 1 Part 1): 243A, 1997

Feasibility of using autologous transplantation to evaluate hematopoietic stem cell-based gene therapy strategies in transgenic mouse models of human disease. Molecular Therapy 6(3): 422-428, 2002

Nonhuman primate allogeneic hematopoietic stem cell transplantation by intraosseus vs intravenous injection: Engraftment, donor cell distribution, and mechanistic basis. Experimental Hematology 36(11): 1556-1566, 2008

Repetitive busulfan administration after hematopoietic stem cell gene therapy associated with a dominant HDAC7 clone in a nonhuman primate. Human Gene Therapy 21(6): 695-703, 2010

Optimization of hematopoietic stem cell transplantation to effect the recombinant AAV-mediated gene therapy of hemoglobinopathies. Molecular Biology of the Cell 12(Suppl.): 522a, 2001

Long-term persistence and function of hematopoietic stem cell-derived chimeric antigen receptor T cells in a nonhuman primate model of HIV/AIDS. Plos Pathogens 13(12): E1006753, 2017

High-level in vivo gene marking after gene-modified autologous hematopoietic stem cell transplantation without marrow conditioning in nonhuman primates. Molecular Therapy 10(3): 469-477, 2004

Gene transfer into nonhuman primate hematopoietic stem cells: implications for gene therapy. Stem Cells 19(1): 12-23, 2001

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells. Journal of Visualized Experiments 2019(144):, 2019

Nonhuman primate embryonic stem cells as a preclinical model for hematopoietic and vascular repair. Experimental Hematology 33(9): 980-986, 2005

In vivo expansion of gene-modified hematopoietic cells by the selective amplifier gene in a nonhuman primate model. Blood 96(11 Part 1): 524a, 2000

Availability of unrelated donors for hematopoietic stem cell transplantation for hemoglobinopathies. Bone Marrow Transplantation 31(7): 547-550, 2003

Transient in vivo beta-globin production after lentiviral gene transfer to hematopoietic stem cells in the nonhuman primate. Human Gene Therapy 20(6): 563-572, 2009